Entactogen research targets social anxiety and isolation across diagnoses, pairing “plasticity windows” with psychotherapy amid shifting FDA scrutiny and evolving trial designs.
Hiroe Hu, DO
Advertisement
Dr Hu is a clinical research fellow in the National Institute of Mental Health's Experimental Therapeutics and Pathophysiology Branch.
Articles by Hiroe Hu, DO
Experts weigh MDMA-like entactogens for social anxiety and depression, neuroplasticity windows, and what FDA setbacks mean for next-wave treatments.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
What Makes Us Human? The Role of Psychiatry and the Future DSM
2
The First Ever Treatment-Resistant Depression Awareness Day
3
Relief Is Not Free: A Case Study of Athlete Cannabis Use
4
How Best to Manage Treatment-Resistant Depression
5